Prehospital thrombolysis in patients with acute ST elevation myocardial infraction - Factor fiction? Results of a survey of the arbeitsgemeinschaft leitende kardiologische krankenhausärzte;Prähospitale thrombolyse bei patienten mit akutem herzinfarkt - Schon routine oder noch die ausnahme? Ergebnisse einer umfrage der arbeitsgemeinschaft leitende kardiologische krankenhausärzte (ALKK)

Notarzt

Volumn 19, Issue 3, 2003, Pages 105-109

  Zeymer, Uwe ^a   Zahn, R ^a   Tebbe, U ^b   Senges, J ^a  

^a Medizinische Klinik B   (Germany)

^b KLINIKUM LIPPE DETMOLD   (Germany)

Author keywords

Acute myocardial infarction; Adjuvant therapy; Prehospital therapy; Registry; Thrombolysis

Indexed keywords

ANISTREPLASE; FIBRINOLYTIC AGENT; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; BLOOD CLOT LYSIS; DEFIBRILLATOR; ELECTROCARDIOGRAPHY MONITORING; GERMANY; HEALTH SURVEY; HEART INFARCTION; HEART MUSCLE REPERFUSION; HUMAN; ST SEGMENT ELEVATION; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0038801742     PISSN: 01772309     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-39535     Document Type: Article

References (22)

1. White HD, Van de Werf FJJ. Thrombolysis for acute myocardial infarction. Circulation 1998; 97: 1632-1646
2. Baigent C, Collins R, Appleby P, Parish S, Sleight P, Peto R, the ISIS-2 Collaborative Group. ISIS-2: 10-year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. BJM 1998; 316: 1337-1343
3. Franzosi MG, Santoro E, De Vita C, Geraci E, Lotto A, Maggioni F, Rovelli F, Santoro L, Tavazzi L, Tognoni G, on behalf of the GISSI Investigators. Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction. Circulation 1998; 98: 2659-2665
4. Vogt A, von Essen R, Tebbe U, Feuerer W, Appel KF, Neuhaus KL. Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies. J Am Coll Cardiol 1993; 21: 1391-1395
5. FTT Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311-322
6. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615-1620
7. Neuhaus KL, Feuerer W, Jeep-Tebbe S, Niederer W, Vogt A, Tebbe U. Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator. J Am Coll Cardiol 1989; 14: 1566-1569
8. Zeymer U, Neuhaus KL. New Thrombolytic agents. In: Cannon CP (ed): Management of Acute Coronary Syndromes. Totowa, USA: Humana Press, 1998: 243-265
9. Morrow DA, Antman EM, Sayah A et al. Evaluation of time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction. J Am Coll Cardiol 2002; 40: 71-77
10. Fath-Ourdoubadi F, Al-Mohammed A, Huehns TY et al. Meta-analysis of randomised trials of prehospital versus hospital thrombolysis. Circulation 1994; 90: 1-325
11. Bonnefoy E, Lapostolle F, Leizorovicz A et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 2002; 360: 825-829
12. Arntz HR, Tebbe U, Schuster HP et al. Leitlinien zur Diagnostik und Therapie des Herzinfarkts in der Prähospitalphase. Z Kardiol 2000; 89: 364-372
13. The European Myocardial Infarction Project Group. Prehospital thrombolytic therapy in patients with suspected myocardial infarction. N Engl J Med 1993; 329: 383-389
14. Zeymer U. Stellenwert der Bolus-Fibrinolytika zur Therapie des akuten Herzinfarkts. Dtsch Med Wschr 2002; 127: 2083-2086
15. The GUSTO III Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 1997; 337: 1118-1123
16. ASSENT-2 Investigators. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction. The ASSENT-2 double blind randomised trial. Lancet 1999; 354: 716-722
17. Giugliano RP, McCabe CH, Antaman EM et al. Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage. Am Heart J 2001; 141: 742-750
18. The ASSENT-3 Investigators. Efficacy and safety of tenecteplase in combination with enoxaparin. Abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet 2001; 338: 605-613
19. Zeymer U. Glycoprotein IIb/IIIa receptor inhibitors in acute ST-elevation myocardial infarction: Will the combination with thrombolytics become reality? J Thrombosis Thrombolysis, 2002 im Druck
20. The GUSTO V Investigators. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Lancet 2001; 357: 1905-1914
21. Genzwürker H, Isovic H, Finteis T et al. Ausstattung von Notarzt-besetzten Rettungsmitteln in Baden-Württemberg. Anästhesist 2002; 51: 367-373
22. Canto JG, Rogers WJ, Bowlby LJ et al. The prehospital electrocardiogram in acute myocardial infarction: is its full potential being realized? J Am Coll Cardiol 1997; 29: 498-505